Corix Bioscience (Corix Bioscience) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Corix Bioscience's long-term debt to total assests ratio for the quarter that ended in Sep. 2017 was 0.00.

Corix Bioscience's long-term debt to total assets ratio declined from Sep. 2016 (0.44) to Sep. 2017 (0.00). It may suggest that Corix Bioscience is progressively becoming less dependent on debt to grow their business.

Corix Bioscience LT-Debt-to-Total-Asset Historical Data

The historical data trend for Corix Bioscience's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience LT-Debt-to-Total-Asset Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.45

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.44	0.45	-	-	-

Corix Bioscience LT-Debt-to-Total-Asset Calculation

Corix Bioscience's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2016 is calculated as

LT Debt to Total Assets (A: Dec. 2016 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2016 )	/	Total Assets (A: Dec. 2016 )
	=	5.077	/	11.37
	=	0.45

Corix Bioscience's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2017 is calculated as

LT Debt to Total Assets (Q: Sep. 2017 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2017 )	/	Total Assets (Q: Sep. 2017 )
	=	0	/	4.344
	=

Corix Bioscience (GREY:CXBS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Corix Bioscience LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines